| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.27B | 2.24B | 2.09B | 2.37B | 1.65B |
| Gross Profit | 324.14M | 292.54M | 256.53M | 123.64M | 97.47M |
| EBITDA | 122.18M | 101.13M | 38.01M | 49.52M | 32.84M |
| Net Income | 2.01M | 2.70M | -45.64M | 16.63M | 9.15M |
Balance Sheet | |||||
| Total Assets | 1.12B | 1.12B | 1.14B | 915.41M | 802.86M |
| Cash, Cash Equivalents and Short-Term Investments | 116.67M | 107.43M | 93.77M | 149.85M | 226.86M |
| Total Debt | 351.15M | 402.21M | 429.44M | 156.58M | 171.05M |
| Total Liabilities | 877.91M | 854.47M | 881.50M | 598.85M | 518.11M |
| Stockholders Equity | 243.53M | 261.94M | 256.45M | 312.28M | 275.86M |
Cash Flow | |||||
| Free Cash Flow | 128.19M | 82.78M | -19.10M | 36.97M | -14.79M |
| Operating Cash Flow | 142.94M | 128.95M | 30.92M | 44.24M | -9.57M |
| Investing Cash Flow | -54.98M | -55.54M | -333.72M | -104.29M | -43.08M |
| Financing Cash Flow | -79.84M | -56.14M | 247.14M | -18.18M | 187.78M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £155.07M | 6.83 | 104.64% | 7.02% | -4.35% | 5.34% | |
69 Neutral | £46.23M | -5.27 | -9.07% | ― | 6.40% | 70.78% | |
68 Neutral | £499.41M | 66.92 | 9.64% | ― | 22.19% | 78.35% | |
64 Neutral | £353.12M | 8.32 | 17.25% | 20.30% | 1.58% | -57.55% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | £754.75M | 413.34 | 3.98% | ― | -0.85% | ― | |
56 Neutral | £35.14M | -11.38 | 31.19% | ― | 25.15% | ― |